Flibanserin CAS 167933-07-5 is a medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. It is marketed under the brand name Addyi and was first approved by the FDA in 2015. Flibanserin works by increasing the levels of certain neurotransmitters in the brain, which are thought to play a role in sexual desire.
Chemical Name:
The chemical name of flibanserin is 1-[2-(4-benzo[b]thiophen-4-yl)piperazin-1-yl]propan-1-one.
Molecular Formula:
The molecular formula of flibanserin is C20H21F3N4OS.
Formula Weight:
The formula weight of flibanserin is 390.47 g/mol.
CAS No:
The CAS number of flibanserin is 167933-07-5.
Top Ten Keywords and Synonyms:
Synonyms:
Health Benefits:
Flibanserin is primarily used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. HSDD is a condition characterized by low or absent sexual desire that causes personal distress or relationship difficulties. Flibanserin has been shown to increase sexual desire and improve sexual function in women with HSDD.
Potential Effects:
In clinical trials, flibanserin has been shown to be effective in increasing sexual desire and improving sexual function in women with HSDD. Women treated with flibanserin reported an increase in satisfying sexual events and a decrease in distress related to their low sexual desire.
Product Mechanism:
Flibanserin works by increasing the levels of certain neurotransmitters in the brain, including serotonin, dopamine, and norepinephrine. These neurotransmitters are thought to play a role in sexual desire. By increasing the levels of these neurotransmitters, flibanserin may help to improve sexual desire in women with HSDD.
Safety:
Like all medications, flibanserin can cause side effects. Patients who have received flibanserin may experience dizziness, fatigue, nausea, or dry mouth. There is also a risk of low blood pressure and fainting, especially when taken with alcohol. Patients should avoid drinking alcohol while taking flibanserin and should discuss the potential risks and benefits of flibanserin with their healthcare provider before starting treatment.
Side Effects:
Common side effects of flibanserin include dizziness, fatigue, nausea, and dry mouth. Serious adverse events associated with flibanserin use include low blood pressure and fainting, especially when taken with alcohol.
Dosing Information:
The dosing of flibanserin is 100 mg once daily at bedtime. Treatment should be continued for at least 8 weeks to assess response. If no improvement is seen after 8 weeks, treatment should be discontinued.
Conclusion:
Flibanserin is a medication used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. By increasing the levels of certain neurotransmitters in the brain, flibanserin may help to improve sexual desire in women with HSDD. However, like all medications, flibanserin can have side effects and may increase the risk of serious adverse events. Patients should discuss the potential risks and benefits of flibanserin with their healthcare provider before starting treatment. It is also important for patients to avoid drinking alcohol while taking flibanserin, as this can increase the risk of low blood pressure and fainting.
